Children's Oncology Group

Children's Oncology Group. The Children's Oncology Group is a National Cancer Institute-supported clinical trials cooperative group, focusing on pediatric oncology research and treatment, in collaboration with institutions such as St. Jude Children's Research Hospital, Dana-Farber Cancer Institute, and University of California, Los Angeles. The group's efforts are also supported by organizations like the American Cancer Society, Cancer Research Institute, and Leukemia & Lymphoma Society. Researchers from Harvard University, Stanford University, and University of Toronto are among those who contribute to the group's work, alongside clinicians from Children's Hospital of Philadelphia and Boston Children's Hospital.

Introduction

The Children's Oncology Group is dedicated to improving the treatment and outcomes of childhood cancer, including leukemia, lymphoma, brain tumors, and solid tumors, through collaborative research efforts with institutions like Memorial Sloan Kettering Cancer Center, University of Chicago, and National Institutes of Health. The group's work is informed by the latest research in genomics, epigenetics, and immunotherapy, as conducted by scientists at Massachusetts Institute of Technology, University of California, San Francisco, and Johns Hopkins University. By working together with organizations like the American Academy of Pediatrics, Society for Pediatric Research, and International Society of Paediatric Oncology, the Children's Oncology Group aims to develop more effective treatments for children with cancer, in partnership with hospitals like NewYork-Presbyterian Hospital and University of Pennsylvania Health System.

History

The Children's Oncology Group was formed in 2000 through the merger of four existing pediatric cancer research groups: the Children's Cancer Group, Pediatric Oncology Group, Intergroup Rhabdomyosarcoma Study Group, and National Wilms Tumor Study Group, with support from the National Cancer Institute and institutions like University of Texas MD Anderson Cancer Center and Fred Hutchinson Cancer Research Center. This merger brought together researchers and clinicians from institutions such as Columbia University, University of Michigan, and Duke University, allowing for greater collaboration and coordination of research efforts, including those with European Society for Paediatric Oncology and International Society of Paediatric Surgical Oncology. The group's history is closely tied to that of Sidney Farber, a pioneer in pediatric oncology who worked at Dana-Farber Cancer Institute and collaborated with researchers at University of California, Berkeley and Yale University.

Research_and_Treatment

The Children's Oncology Group conducts research in a wide range of areas, including cancer biology, clinical trials, and quality of life studies, in collaboration with institutions like University of Washington, University of Pittsburgh, and Baylor College of Medicine. The group's research is focused on developing more effective treatments for childhood cancer, including chemotherapy, radiation therapy, and surgery, as well as innovative approaches like immunotherapy and gene therapy, with input from experts at University of California, Los Angeles, University of Illinois at Chicago, and Case Western Reserve University. Researchers from University of North Carolina at Chapel Hill, University of Wisconsin-Madison, and Vanderbilt University are among those who contribute to the group's work, alongside clinicians from Seattle Children's Hospital and Children's Hospital of Wisconsin.

Organization_and_Membership

The Children's Oncology Group is a member-based organization, with over 200 hospitals and institutions participating in its research efforts, including University of Southern California, University of Minnesota, and Ohio State University. The group's membership includes researchers, clinicians, and other healthcare professionals from institutions like University of Florida, University of Georgia, and University of Iowa, as well as organizations like the American Society of Clinical Oncology and Society for Pediatric Research. The group is governed by a board of directors, which includes representatives from institutions like Stanford University, University of Pennsylvania, and Washington University in St. Louis, and is supported by the National Cancer Institute and other funding agencies, such as the National Institutes of Health and Cancer Research Institute.

Clinical_Trials

The Children's Oncology Group conducts clinical trials to evaluate new treatments for childhood cancer, in collaboration with institutions like MD Anderson Cancer Center, University of California, San Diego, and University of Colorado Denver. The group's clinical trials are designed to assess the safety and efficacy of new therapies, including immunotherapy and targeted therapy, and to compare the effectiveness of different treatment approaches, with input from experts at University of Virginia, University of Utah, and University of Nebraska Medical Center. Researchers from University of Oklahoma, University of Kansas, and University of Missouri are among those who contribute to the group's clinical trials, alongside clinicians from Children's Mercy Hospital and Nationwide Children's Hospital, and with support from organizations like the Leukemia & Lymphoma Society and St. Baldrick's Foundation. The group's clinical trials are conducted at member institutions, including University of Alabama at Birmingham, University of Arizona, and University of Arkansas for Medical Sciences, and are overseen by the National Cancer Institute and other regulatory agencies, such as the Food and Drug Administration and Institutional Review Board.